The art of drug synthesis / edited by Douglas S. Johnson, Jie Jack Li.
Contributor(s): Johnson, Douglas S. (Douglas Scott) | Li, Jie Jack.
Publisher: Hoboken, N.J. : Wiley-Interscience, c2007Description: xv, 276 p. : ill. ; 26 cm.ISBN: 9780471752158 (hbk.); 0471752150 (hbk.).Subject(s): Drugs -- Design | Pharmaceutical chemistryDDC classification: 615.19Item type | Current location | Call number | Copy number | Status | Notes | Date due | Barcode | Remark |
---|---|---|---|---|---|---|---|---|
SOM Main Collection | TU External Storage-LCS | 615.19 ART 2007 (Browse shelf) | 1 | Available | SOMxx,33001,03,CL | 5000111563 | Please fill up online form at https://taylorslibrary.taylors.edu.my/services/external_storage1 |
Browsing Taylor's Library-TU Shelves Close shelf browser
615.19 APP 2011 Applications of microdialysis in pharmaceutical science / | 615.19 APP 2014 Applied physical pharmacy / | 615.19 ARO 2010 Name reactions and organic drugs synthesis : | 615.19 ART 2007 The art of drug synthesis / | 615.19 AUL 2009 Aulton's pharmaceutics : | 615.19 AUL 2009 Aulton's pharmaceutics : | 615.19 AUL 2009 Aulton's pharmaceutics : |
Includes bibliographical references and index.
The role of medicinal chemistry in drug discovery / John A. Lowe III -- Process research: how much? how soon? / Neal G. Anderson -- Aromatase inhibitors for breast cancer : exemestane (Aromasin), anastrozole (Arimidex), and letrozole (Femara) / Jie Jack Li -- Quinolone antibiotics : levofloxacin (Levaquin), moxifloxacin (Avelox), gemifloxacin (Factive), and garenoxacin (T-3811) / Chris Limberakis -- Triazole antifungals : itraconazole (Sporanox), fluconazole (Diflucan), voriconazole (Vfend), and fosfluconazole (Prodif) / Andrew S. Bell -- Non-nucleoside HIV reverse transcriptase inhibitors / Arthur Harms -- Neuraminidase inhibitors for influenza : oseltamivir phosphate (Tamiflu) and zanamivir (Relenza) / Douglas S. Johnson and Jie Jack Li -- Peroxisome proliferator-activated receptor (PPAR) agonists for type 2 diabetes / Jin Li -- Angiotensin AT1 antagonists for hypertension / Larry Yet -- Leading ACE inhibitors for hypertension / Victor J. Cee and Edward J. Olhava -- Dihydropyridine calcium channel blockers for hypertension / Daniel P. Christen -- Second-generation HMG-CoA reductase inhibitors / Jeffrey A. Pfefferkorn -- Cholesterol absorption inhibitors: ezetimibe (zetia) / Stuart B. Rosenblum -- Dual selective serotonin and norepinephrine reuptake inhibitors (SSNRIs) for depression / Marta Piñeiro-Núñez -- GABA receptor agonists for insomnia : zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Estorra, Lunesta), and indiplon / Peter R. Guzzo -- Ligands: neurontin (Gabapentin) and lyrica (Pregabalin) / Po-Wai Yuen -- Approved treatments for attention deficit hyperactivity disorder : amphetamine (Adderall), methylphenidate (Ritalin), and atomoxetine (Straterra) / David L. Gray.